About ImQuest Pharma Therapeutic Focus Product Pipeline Scientific Staff News & Notes Investor Relation Contact Us Careers
  
 
Therapeutic Focus
General Information
Infectious Disease
Cancer
Topical Microbicides
Immune Modulation and
Inflammation
News and Notes
April 4th 2008:
ImQuest scientists present important HIV Microbicide results at Microbicides 2008 in Delhi, India.
   
April 1st 2008:
ImQuest publishes results of structure activity relationship study with pyrimidinedione HIV inhibitors.
   
September 24th 2007:
ImQuest Life Sciences announces the appointment of Robert Schooley, M.D. to its Scientific Advisory Board.
   
September 21st 2007:
ImQuest Life Sciences announces the appointment of David Ho, M.D. to its Scientific Advisory Board.
   
September 20th 2007:
ImQuest Life Sciences announces the appointment of Richard J. Whitley, M.D. as Chairman of its Scientific Advisory Board.
   
April 25th 2007:
ImQuest Life Sciences Receives Grant from International Partnership
for Microbicides to Develop Novel Microbicide
   
April 25th 2006:
ImQuest Life Sciences Licenses Piperazine Series of Anti-Cancer Therapeutic
Compounds from Samjin Pharmaceutical Co.
   
 News Archieve
Welcome to ImQuest Life Sciences Welcome to ImQuest Life Sciences
Meet the Management
About ImQuest | Directors and Advisors

Daniel R. Caffoe, Chief Executive Officer
Robert W. Buckheit, Executive Vice President and Chief Scientific Officer
Dan Williams, JD, LLM, Vice President of Tax and Chief Financial Officer
 
Todd B. Parsley, Ph.D. - Director, Biological Sciences
Paul J. Henry, Esq., Vice President of Strategic Development
David Miller, Vice President of Drug Development Affairs
  Joseph F.X. McGuirl
 
Daniel R. Caffoe, Chief Executive Officer
Daniel R. CaffoeMr. Caffoe is a founding member of the family of ImQuest Companies which began in 2001 and he became the interim CEO and Chairman of ImQuest Life Sciences early in 2008. He has been a very important part of the company’s reorganization that began late in 2007 and has implemented a new development plan to recruit new management that will allow ImQuest to raise the additional funds needed to move the company’s products to human clinical trials. From 1979 until 1993 Mr. Caffoe owned and operated his own golf facilities and then in 1994 he became a Life Member of the Professional Golfers Association of America. Mr. Caffoe is currently a licensed Insurance and Mortgage Broker in the State of Indiana. He has also been involved in the real estate industry as an investor and developer and has owned and operated a number of different businesses during his lifetime.
Infectious Disease
IQP-0410 for  HIV
HBV Lead Discovery
Anti-Cancer Agents
IQP-0303 for
leukemia
IQP-0304 for prostate
cancer
Topical Microbicides
IQP-0528
IQP-0831
IQP-1187
Copyright © 2006, ImQuest Life Sciences. Site Map | Search | Privacy Policy | Terms & Conditions. Site by Synapse Communications.